This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) | MicrobiomeTrials
← Back to trials NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-08-16Est. Completion: 2029-03-31
Enrollment target: 90 participantsLocations Children's Hospital Los Angeles ( Site 1006), Los Angeles, California, United States Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora, Colorado, United States Yale New Haven Hospital ( Site 1012), New Haven, Connecticut, United States Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg, Florida, United States University of Iowa-Holden Comprehensive Cancer Center ( Site 1017), Iowa City, Iowa, United States Dana-Farber Cancer Institute ( Site 1013), Boston, Massachusetts, United States Corewell Health ( Site 1001), Grand Rapids, Michigan, United States Children's Mercy Hospital ( Site 1024), Kansas City, Missouri, United States Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick, New Jersey, United States Memorial Sloan Kettering Cancer Center ( Site 1010), New York, New York, United States New York Medical College ( Site 1023), Valhalla, New York, United States Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo, North Dakota, United States Oregon Health and Science University ( Site 1004), Portland, Oregon, United States Other microbiome trials you might be interested in B-All Acute Lymphoblastic Leukemia
Background:
Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…
Los Angeles, United States Est. completion Dec 31, 2026
Diffuse Large B-cell Lymphoma (DLBCL) Cardiotoxicity Lymphoma
This trial is to evaluate if dexrazoxane is safer and more effective than liposomal doxorubicin in preventing heart fail…
Boston, United States Est. completion Dec 31, 2030
Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia, Pennsylvania, United States
Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls, South Dakota, United States
University of Texas MD Anderson Cancer Center ( Site 1007), Houston, Texas, United States
Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City, Utah, United States
Sydney Children's Hospital ( Site 1997), Randwick, New South Wales, Australia
Queensland Children's Hospital-Oncology & Haematology ( Site 1996), Brisbane, Queensland, Australia
Royal Children's Hospital-Children's Cancer Centre ( Site 1994), Melbourne, Victoria, Australia
UZ Gent ( Site 1428), Ghent, Oost-Vlaanderen, Belgium
Hospital Erasto Gaertner-CEPEP - Pesquisa Clínica ( Site 1268), Curitiba, Paraná, Brazil
Hospital de Clinicas de Porto Alegre ( Site 1265), Porto Alegre, Rio Grande do Sul, Brazil
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1264), Barretos, São Paulo, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site 1267), São José do Rio Preto, São Paulo, Brazil
Alberta Children's Hospital ( Site 1227), Calgary, Alberta, Canada
The Hospital for Sick Children ( Site 1225), Toronto, Ontario, Canada
McGill University Health Centre-Pediatric HematologyOncology ( Site 1223), Montreal, Quebec, Canada
Hospital Clínico Regional Dr. Guillermo Grant Benavente ( Site 1881), Concepción, Biobio, Chile
Hospital Luis Calvo Mackenna ( Site 1879), Santiago, Region M. de Santiago, Chile
Hospital Carlos Van Buren ( Site 1880), Valparaíso, Valparaiso, Chile
Hospital Pablo Tobon Uribe ( Site 1923), Medellín, Antioquia, Colombia
Clinica de la Costa S.A.S.-Clinical Research Oncology & Hematology -Pediatric ( Site 1924), Barranquilla, Atlántico, Colombia
IMAT S.A.S ( Site 1921), Montería, Departamento de Córdoba, Colombia
Detska nemocnice FN Brno ( Site 1388), Brno, Brno-mesto, Czechia
Fakultni nemocnice v Motole-Klinika detske hematologie a onkologie ( Site 1387), Prague, Praha 5, Czechia
Rigshospitalet-Department of paediatrics and adolescent medicine, Section of Paed haem-onc ( Site 1467), Copenhagen, Capital Region, Denmark
CHU de Bordeaux. Hopital Pellegrin ( Site 1105), Bordeaux, Aquitaine, France
CENTRE LEON BERARD-IHOPE (pediatrric oncology) ( Site 1100), Lyon, Auvergne-Rhône-Alpes, France
Centre Hospitalier Universitaire de Nantes - Hôpital Femme-Enfant-Adolescent Chu De Nantes ( Site 1104), Nantes, Loire-Atlantique, France
Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone ( Site 1102), Marseille, Provence-Alpes-Côte d'Azur Region, France
Gustave Roussy ( Site 1103), Villejuif, Île-de-France Region, France
Universitaetsklinikum Tuebingen ( Site 1142), Tübingen, Baden-Wurttemberg, Germany
Universitaetsklinikum Koeln. Klinik und Poliklinik ( Site 1145), Cologne, North Rhine-Westphalia, Germany
Universitätsklinikum Münster - Albert Schweitzer Campus-Pädiatrische Hämatologie und Onkologie ( Site 1141), Münster, North Rhine-Westphalia, Germany
Charité Campus Virchow-Klinikum-Klinik für Pädiatrie mit Schwerpunkt Hämatologie und Onkologie ( Site 1143), Berlin, Germany
Aghia Sophia Children's Hospital-First Department of Pediatrics, National and Kapodistrian Universi ( Site 1797), Athens, Attica, Greece
Semmelweis Egyetem ( Site 1838), Budapest, Hungary
Rambam Health Care Campus-Pediatric Hemato-Oncology ( Site 1674), Haifa, Israel
Sheba Medical Center ( Site 1675), Ramat Gan, Israel
Fondazione IRCCS Istituto Nazionale dei Tumori-Pediatric Oncology ( Site 1552), Milan, Lombardy, Italy
Ospedale Pediatrico Bambino Gesù IRCCS-Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica ( Site 1553), Rome, Roma, Italy
Ospedale Infantile Regina Margherita-S.C. Oncoematologia Pediatrica ( Site 1551), Torino, Italy
Prinses Maxima Centrum voor Kinderoncologie ( Site 1510), Utrecht, Netherlands
Narodny ustav detskych chorob ( Site 1592), Bratislava, Bratislava Region, Slovakia
Seoul National University Hospital-Pediatrics ( Site 1972), Seoul, South Korea
Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 1973), Seoul, South Korea
Hospital Sant Joan de Déu-Pediatric Oncology Department ( Site 1717), Esplugas de Llobregat, Barcelona, Spain
Hospital Infantil Universitario Niño Jesús-Servicio de Onco-Hematología Pediátrica ( Site 1715), Madrid, Madrid, Comunidad de, Spain
Hospital Universitario y Politecnico La Fe de Valencia ( Site 1718), Valencia, Valenciana, Comunitat, Spain
Hospital Universitari Vall d'Hebron-Servei de Hematologia i Oncologia Pediatrica ( Site 1716), Barcelona, Spain
Sahlgrenska Universitetssjukhuset ( Site 1634), Gothenburg, Västra Götaland County, Sweden
National Taiwan University Hospital ( Site 1983), Taipei, Taiwan
Ege Universitesi Hastanesi ( Site 1963), Bornova, İzmir, Turkey (Türkiye)
Hacettepe Universite Hastaneleri ( Site 1961), Ankara, Turkey (Türkiye)
Ankara Bilkent Şehir Hastanesi ( Site 1962), Ankara, Turkey (Türkiye)
Birmingham Children's Hospital-Oncology/Haematology ( Site 1349), Birmingham, England, United Kingdom
Royal Victoria Infirmary-Great North Children's Hospital ( Site 1348), Newcastle upon Tyne, England, United Kingdom
University College London Hospital ( Site 1350), London, London, City of, United Kingdom
Royal Marsden Hospital (Sutton)-Drug Development Unit ( Site 1347), Sutton, Surrey, United Kingdom
University Hospital of Wales ( Site 1346), Cardiff, United Kingdom